Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Cryovial Preparation and Sample Packaging

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the preparation, labeling, and aliquoting of cryovials containing extracted DNA, intended for long-term storage and subsequent shipment to the Center for Alzheimer’s Disease Research (CARD). The contract requires meticulous handling to ensure sample integrity during storage and transport. The work is to be performed in Colchester, with a focus on adhering to quality standards appropriate for biological sample management. Issued by the National Institutes of Health under the Department of Health and Human Services, this subcontract falls under the NAICS code 325414, which pertains to biological product preparation. The solicitation was posted on June 11, 2026, and all responses must be submitted by June 23, 2026, at 3:00 PM. While some administrative details like the point of contact and complete office address are not specified, the contract emphasizes timely and precise execution within the defined timeframe.

General Info

Prepare, label, aliquot DNA cryovials in Colchester for long-term storage and shipment to CARD.

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing View NAICS

Place of Performance

Colchester, VT, 05446, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Prepare, label, and aliquot cryovials containing extracted DNA for long-term storage and shipment to CARD.

Similar Contracts

NAICS: 325414
New
Federal
iNDI FA13.1J Cell Lines Expansion and Distribution for the iPSC Neurodegenerative Disease Initiative (iNDI) ProjectThe Department of Health and Human Services, through the National Institutes of Health's National Institute on Aging, intends to award a sole source contract to The Jackson Laboratory for the expansion, quality control, biobanking, and distribution of isogenic Alzheimer’s disease and related dementias induced pluripotent stem cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) Project. This contract will focus on providing up to 936 specific iPSC lines, including 486 FA13.1J female SNV lines and 450 lines across 25 high-priority SNV trios, adhering to iNDI protocols for quality and expansion. The Jackson Laboratory is uniquely qualified for this contract as it currently houses the existing distribution infrastructure and has demonstrated successful past performance in supporting NIH’s iNDI requirements. The contract is planned to be a firm-fixed-price agreement with a performance period starting September 1, 2026, for a base year and up to three option years, ending August 31, 2030. The primary place of performance will be the contractor’s facility in Bar Harbor, Maine. While this notice signals the intent for a sole source award, other capable sources may submit capability statements demonstrating their ability to meet the outlined requirements, including supply of the specific cell lines, adherence to quality protocols, product and web content creation, and public distribution via an established platform. Responses must be submitted electronically by June 23, 2026, and the Government reserves the right to consider all responses but is under no obligation to initiate a competitive procurement.
National Institutes Of Health Olao

POSTED

6 days ago

DEADLINE

in 7 days
View Details